Etoposide in Treating Patients With Advanced Ovarian or Cervical Cancer

Stopped early · Phase 2

Conditions studied: Cervical Cancer, Ovarian Cancer

In brief

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of etoposide in treating patients who have refractory, recurrent, or metastatic ovarian or cervical cancer.

Key facts

Study ID
NCT00002478
Run by
Gynecologic Oncology Group
Starts
1993-06-01
Last updated by the study team
2013-06-10

Who can join

Age: any. Sex: female. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.